Belatacept Early Steroid Withdrawal Trial

NCT01729494 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

316

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplantation

Interventions

DRUG: Alemtuzumab
DRUG: rabbit antithymocyte globulin
DRUG: Belatacept
DRUG: Tacrolimus
DRUG: Mycophenolate mofetil
DRUG: early cessation of steroids

Sponsor

University of Cincinnati